Dr. Manohar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2615- Is this information wrong?
Summary
- I am a board-certified medical oncologist who specializes in the treatment of breast cancer. My approach to care is holistic, integrating both your physical and emotional well-being. I cherish the opportunity to listen to your concerns, share in decision-making and develop a treatment plan that aligns with your personal goals and wishes.
In addition to working closely with patients and families, I am privileged to partner with the Hutchinson Institute for Cancer Outcomes Research (HICOR). Based at Fred Hutch, this research institute uses cancer-related data to improve the delivery of care. I have been awarded multiple grants to assess the management of patients with metastatic breast cancer across Washington state. My goal is to better understand disparities in access to care. I hope to build a career in academia that focuses on developing a model of accessible, affordable and sustainable care for all patients.
Education & Training
Wright State University Boonshoft School of MedicineClass of 2013
Certifications & Licensure
WA State Medical License 2017 - 2024
TX State Medical License 2023 - 2024
MI State Medical License 2013 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 7 citationsUpdates in endocrine therapy for metastatic breast cancer.Poorni Manohar, Nancy E. Davidson> ;Cancer Biology & Medicine. 2021 Oct 5
- 2 citationsEconomic Impact of Imaging Overutilization in Cancer Care.Poorni Manohar, Scott D. Ramsey, Veena Shankaran> ;Journal of the American College of Radiology. 2020 Jan 1
- 14 citationsCost effectiveness analysis of direct oral anticoagulant (DOAC) versus dalteparin for the treatment of cancer associated thrombosis (CAT) in the United States.Ang Li, Poorni Manohar, David A. Garcia, Gary H. Lyman, Lotte Maria Gertruda Steuten> ;Thrombosis Research. 2019 Aug 1
- Join now to see all
Press Mentions
What’s New in Breast Cancer Research? SABCS 2022 Delivers PlentyDecember 14th, 2022- ASCO 2022: Equity, Innovation and in-PersonJune 9th, 2022
Risk vs. Benefit: Bisphosphonates in Breast CancerMay 4th, 2021- Join now to see all
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
University of Texas Southwestern Medical CenterDallas, Texas
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
